Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Maggioni

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|January 13, 2005
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosisDomenico Alvaro, Pietro Invernizzi, Paolo Onori, et al.
Biochemical Pharmacology|November 19, 2023
A novel gene signature to diagnose MASLD in metabolically unhealthy obese individualsMarica Meroni, Federica Chiappori, Erika Paolini, et al.
Nature Communications|August 13, 2021
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinomaAlessandra Scagliola, Annarita Miluzio, Gabriele Ventura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancyAmedeo Sciarra, Sabine Schmidt, Alessandro Pellegrinelli, et al.
BMJ (Clinical Research Ed.)|March 5, 2005
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trialSavino Bruno, Patrick Maisonneuve, Paola Castellana, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 2, 2017
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation studyAmedeo Sciarra, Bogdan Pintea, Ji Hae Nahm, et al.
Obesity (Silver Spring, Md.)|March 5, 2024
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLDMarica Meroni, Emilia De Caro, Federica Chiappori, et al.
Orphanet Journal of Rare Diseases|April 5, 2018
KARS-related diseases: progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literatureAnna Ardissone, Davide Tonduti, Andrea Legati, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|September 8, 2015
Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implicationsAmedeo Sciarra, Luca Di Tommaso, Masayuki Nakano, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|January 13, 2005
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosisDomenico Alvaro, Pietro Invernizzi, Paolo Onori, et al.
Biochemical Pharmacology|November 19, 2023
A novel gene signature to diagnose MASLD in metabolically unhealthy obese individualsMarica Meroni, Federica Chiappori, Erika Paolini, et al.
Nature Communications|August 13, 2021
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinomaAlessandra Scagliola, Annarita Miluzio, Gabriele Ventura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancyAmedeo Sciarra, Sabine Schmidt, Alessandro Pellegrinelli, et al.
BMJ (Clinical Research Ed.)|March 5, 2005
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trialSavino Bruno, Patrick Maisonneuve, Paola Castellana, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 2, 2017
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation studyAmedeo Sciarra, Bogdan Pintea, Ji Hae Nahm, et al.
Obesity (Silver Spring, Md.)|March 5, 2024
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLDMarica Meroni, Emilia De Caro, Federica Chiappori, et al.
Orphanet Journal of Rare Diseases|April 5, 2018
KARS-related diseases: progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literatureAnna Ardissone, Davide Tonduti, Andrea Legati, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.
Journal of Hepatology|September 8, 2015
Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implicationsAmedeo Sciarra, Luca Di Tommaso, Masayuki Nakano, et al.
Pageof 11